1800 244 735

Helpline (02) 9874 9777

UPDATE from ROCHE clinical research program into HD drugs

ROCHE / GENENTECH have released a statement:

Update on tominersen (RG6042)* Huntington’s disease (HD) clinical programme: Recruitment into GENERATION HD1 clinical trial has been completed

You can read the statement in full here.

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest News and Stories

Neurological Alliance Australia Position Statement on Aged Care – Dec 2020

Published date: 13 January, 2021

Huntington’s NSW ACT is a member of the Neurological Alliance Australia on behalf of all State Associations. This Position Statement on Aged Care comes with an important reminder that over half of those with HD living in residential care are in aged care homes.

The Year That Was….

Published date: 8 December, 2020

As we approach the end of the year and the Christmas holidays we are all a little unsure whether we will be getting together with family members and loved ones to share the festive season in the way we always do. One thing we can be sure of is that we will look back on ... Read more
Person taking notes at a meeting

Community Survey 2020

Published date: 6 December, 2020

Participate by 31/12/20 for your chance to WIN a free weekends accomodation near Wollombi.
International Day of People with Disability logo

International Day of People with Disability

Published date: 2 December, 2020

We are committed to empowering people with HD to live their best possible life. We want to see all people impacted by HD treated with equity by governments, other institutions and their communities. #idpwd #disablestereotypes #advocacymatters #abilitynotdisability #huntingtonsdisease

Prof Elizabeth McCusker interview

Published date: 25 November, 2020

Special guest speaker at our 2020 annual general meeting to recognise her retirement after many years as both a clinical and research leader.

Hunt4Hope Op Shop

Published date: 17 November, 2020

The Hunt4Hope Shop is a self-funded business where Matina, the owner, chooses to give 100% of the profits to Huntington’s NSW ACT who helps those affected by Huntington’s Disease.